A Study of TMC435 Plus Pegylated Interferon Alfa-2a and Ribavirin in Participants With Chronic HCV Infection

Clinical trial NCT01846832 · COMPLETED

Trial details

NCT number: NCT01846832
Sponsor: Janssen-Cilag International NV
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C, Chronic Infection

Start date: 2013-09-01
Primary completion: 2015-08-01
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.